DNA technology has been used to diagnose parvovirus B19 infection in clinical samples. The tests are specific and can attain a high degree of sensitivity, particularly when using PCR amplification. Over the next few years, DNA technology will become increasingly available and may be among the routine diagnostic tests in the future.